CPHI & PMEC China

Over three days in Shanghai, it connects buyers and suppliers spanning pharmaceutical ingredients, contract services and outsourcing, biopharma capabilities, machinery and processing equipment, packaging, and associated technologies. It’s widely used as a high-efficiency platform for identifying new suppliers, benchmarking capabilities, and progressing commercial discussions in the Chinese and wider Asia-Pacific pharma markets.

Who the audience is and how many attend

Audience

• API, excipient and ingredient manufacturers, distributors and traders
• Pharma and biotech manufacturers and procurement teams
• CDMOs/CMOs and contract service providers (development, manufacturing, packaging, analytics)
• Biopharma and technology companies supporting biologics and advanced modalities
• Machinery, equipment, packaging and lab/QC solution providers
• Quality, regulatory, supply chain and operations leaders

Scale

• Large, multi-hall exhibition at SNIEC with extensive co-located pharma sectors (CPHI + PMEC and related shows)
• The organiser positions it as a major Asia-focused marketplace; headline totals for attendees/exhibitors can vary by edition and co-located show mix.

What to expect

• A large-scale exhibition spanning ingredients, outsourcing, biopharma, manufacturing equipment and packaging
• High-density networking and sourcing meetings with Chinese and international suppliers
• Content and seminars focused on market trends, regulation, manufacturing priorities and innovation in the China/Asia pharma landscape
• An efficient “one trip” format due to the co-located shows, enabling broad supplier discovery and partner comparison across the supply chain